Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
50,733,997
-
Share change
-
+5,578,008
-
Total reported value
-
$295,822,953
-
Put/Call ratio
-
96%
-
Price per share
-
$5.83
-
Number of holders
-
160
-
Value change
-
+$31,944,283
-
Number of buys
-
79
-
Number of sells
-
59
Institutional Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q3 2020
As of 30 Sep 2020,
CLOVIS ONCOLOGY INC - COM (CLVSQ) was held by
160 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,733,997 shares.
The largest 10 holders included
STATE STREET CORP, VANGUARD GROUP INC, BlackRock Inc., Palo Alto Investors LP, MORGAN STANLEY, ARMISTICE CAPITAL, LLC, CITADEL ADVISORS LLC, Candriam Luxembourg S.C.A., GEODE CAPITAL MANAGEMENT, LLC, and NATIXIS.
This page lists
160
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.